Literature DB >> 19080738

The decline in breast cancer incidence: real or imaginary?

Allison W Kurian1, Christina A Clarke, Robert W Carlson.   

Abstract

Breast cancer is a major global problem, with nearly 1 million cases occurring each year. Over the past several decades, the disease's incidence has risen worldwide, increasing in developing and developed countries. This rise in breast cancer incidence has been attributed to changes in lifestyle and reproductive factors and to the dissemination of population-wide mammographic screening, which facilitates diagnosis. Recently, a decline in breast cancer incidence was reported in the United States and several other developed countries, and a substantial reduction in menopausal hormone therapy use was proposed as a possible cause. However, significant controversy remains as to the timing, causes, generalizability, and longevity of this reported decline in incidence.

Entities:  

Mesh:

Year:  2009        PMID: 19080738     DOI: 10.1007/s11912-009-0005-7

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  49 in total

1.  UK death rates from breast cancer fall by a third.

Authors:  P Brown
Journal:  BMJ       Date:  2000-10-07

2.  A decline in breast-cancer incidence.

Authors:  Per-Henrik Zahl; Jan Maehlen
Journal:  N Engl J Med       Date:  2007-08-02       Impact factor: 91.245

3.  A decline in breast-cancer incidence.

Authors:  Lisa B Signorello; Robert E Tarone
Journal:  N Engl J Med       Date:  2007-08-02       Impact factor: 91.245

4.  Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.

Authors:  Benjamin O Anderson; Roman Shyyan; Alexandru Eniu; Robert A Smith; Cheng-Har Yip; Nuran Senel Bese; Louis W C Chow; Shahla Masood; Scott D Ramsey; Robert W Carlson
Journal:  Breast J       Date:  2006 Jan-Feb       Impact factor: 2.431

5.  Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income.

Authors:  Feifei Wei; Diana L Miglioretti; Maureen T Connelly; Susan E Andrade; Katherine M Newton; Cynthia L Hartsfield; K Arnold Chan; Diana S M Buist
Journal:  J Natl Cancer Inst Monogr       Date:  2005

6.  Population-based mammography screening and breast cancer incidence in New South Wales, Australia.

Authors:  Clayton Chiu; Stephen Morrell; Andrew Page; Mary Rickard; Ann Brassil; Richard Taylor
Journal:  Cancer Causes Control       Date:  2006-03       Impact factor: 2.506

7.  Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

Authors:  Marcia L Stefanick; Garnet L Anderson; Karen L Margolis; Susan L Hendrix; Rebecca J Rodabough; Electra D Paskett; Dorothy S Lane; F Allan Hubbell; Annlouise R Assaf; Gloria E Sarto; Robert S Schenken; Shagufta Yasmeen; Lawrence Lessin; Rowan T Chlebowski
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

Review 8.  Declines in breast cancer after the WHI: apparent impact of hormone therapy.

Authors:  Christina A Clarke; Sally L Glaser
Journal:  Cancer Causes Control       Date:  2007-07-06       Impact factor: 2.506

9.  The decrease in breast-cancer incidence in 2003 in the United States.

Authors:  Peter M Ravdin; Kathleen A Cronin; Nadia Howlader; Christine D Berg; Rowan T Chlebowski; Eric J Feuer; Brenda K Edwards; Donald A Berry
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

10.  Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.

Authors:  Karla Kerlikowske; Diana L Miglioretti; Diana S M Buist; Rod Walker; Patricia A Carney
Journal:  J Natl Cancer Inst       Date:  2007-08-14       Impact factor: 13.506

View more
  5 in total

1.  Cancer incidence trends among Asian American populations in the United States, 1990-2008.

Authors:  Scarlett Lin Gomez; Anne-Michelle Noone; Daphne Y Lichtensztajn; Steve Scoppa; James T Gibson; Lihua Liu; Cyllene Morris; Sandy Kwong; Kari Fish; Lynne R Wilkens; Marc T Goodman; Dennis Deapen; Barry A Miller
Journal:  J Natl Cancer Inst       Date:  2013-07-22       Impact factor: 13.506

2.  Ixabepilone as monotherapy or in combination with capecitabine for the treatment of advanced breast cancer.

Authors:  Katherine H Rak Tkaczuk
Journal:  Breast Cancer (Auckl)       Date:  2011-01-13

3.  17α-ethynyl-5α-androstane-3α, 17β-diol treatment of MNU-induced mammary cancer in rats.

Authors:  Clarence N Ahlem; James M Frincke; Steven K White; Christopher L Reading; Richard J Trauger; Rajkumar Lakshmanaswamy
Journal:  Int J Breast Cancer       Date:  2011-02-14

4.  Breast cancer policy in Latin America: account of achievements and challenges in five countries.

Authors:  Gustavo Nigenda; Maria Cecilia Gonzalez-Robledo; Luz Maria Gonzalez-Robledo; Rosa Maria Bejarano-Arias
Journal:  Global Health       Date:  2016-07-12       Impact factor: 4.185

5.  Reproductive factors and breast cancer risk: A meta-analysis of case-control studies in Indian women.

Authors:  Gayatri Vishwakarma; Harrison Ndetan; Durgesh Nandini Das; Garima Gupta; Moushumi Suryavanshi; Anurag Mehta; Karan P Singh
Journal:  South Asian J Cancer       Date:  2019 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.